Print

---

DBS vs. CCT

A following comparison is drawn on factual information, for education purpose ONLY. This is offered in the hope of giving each patient a concise view, so that s/he has a better idea of what is the best course of action to help her/him overcome her/his condition:

(As per Garg's definitive therapy)

Deep Brain Stimulation (DBS) 

  1.. Stimulates the Subthalamus by electric wires (PD does NOT occur in Subthalamus)
  2.. Subthalamus does NOT produce dopamine inhibition (neither do electric wires).
  3.. Therefore, patient REQUIRES dopamine, throughout life-time, even AFTER DBS.
  4.. Results in FALSE reduction of medications (Initially, overdose to "sell" DBS; afterwards, reduce med).
  5.. No medical rationale for it to"work". After DBS, patients have asked for removal, as they are miserable.
  6.. Only temporary relief, for a few months. Does NOT stop worsening of PD.
  7.. Patients have experienced side-effects, complications, infections, maladjustment, including death.
  8.. Has NO capacity to regenerate or revive dopamine-producing cells.
  9.. Commercially promoted, on false
  data, to influence FDA.

  10.. Lately, Medtronics to replace DBS
by GDNF infusion, as DBS failing.

Cord Cell Therapy (CCT) 


  1.. Stereotactic MRI-guided transplant of functional nerve cells in the nigra of the brain-stem, where PD occurs.
  2.. Nigral nerve cells produce dopamine within one year, after transplantation (under local anesthesia ONLY). 
  3.. Therefore, patient tapers dopamine intake gradually, according to the improvement level.
  4.. Results in TRUE reduction of meds, 
  as dopamine gradually increases,

  under physiological control. 

  5.. ALL medically valid rationale for it
  to "work". CCT done in patients,

  After they have had DBS previously.

  6.. Most definitive therapy for relief and is Safe; as PD does NOT worsen any further.
  7.. No complication, including No bleeding, or infection; No side-effects. And, No mortality.
  8.. New functional cells REPLACE the dead cells in the nigra of brain-stem.
  9.. Only umbilical cord cells, per AABB guidelines. Too early for FDA view.
  10.. No GDNF required, as new glial cells produce GDNF in CCT.

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn